0000906791-26-000140.txt : 20260715 0000906791-26-000140.hdr.sgml : 20260715 20260715112528 ACCESSION NUMBER: 0000906791-26-000140 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20260715 DATE AS OF CHANGE: 20260715 EFFECTIVENESS DATE: 20260715 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ASA-US Building Blocks Series, LP - ASA-US Equity Long Short Biotech Strategy CENTRAL INDEX KEY: 0002123821 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-590835 FILM NUMBER: 261176509 BUSINESS ADDRESS: STREET 1: 450 PARK AVENUE STREET 2: 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 914-608-9319 MAIL ADDRESS: STREET 1: 90 PARK AVENUE, 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 D 1 primary_doc.xml X0708 D LIVE 0002123821 ASA-US Building Blocks Series, LP - ASA-US Equity Long Short Biotech Strategy 450 PARK AVENUE 5TH FLOOR NEW YORK NY NEW YORK 10022 914-608-9319 DELAWARE None None Limited Partnership true 2026 n/a ASA-US Building Blocks Series GP, LLC 450 PARK AVENUE 5TH FLOOR New York NY NEW YORK 10022 Executive Officer Promoter General Partner of the Issuer n/a ASA Asset Management LLC 450 PARK AVENUE 5TH FLOOR New York NY NEW YORK 10022 Executive Officer Promoter Investment Manager of the Issuer Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.7 false 2026-06-30 true true true false 10000 Indefinite 341000 Indefinite false 2 0 true 0 true 0 true The Fund charges a management fee that is described in the Fund's governing documents. false ASA-US Building Blocks Series, LP - ASA-US Equity Long Short Biotech Strategy /s/ Charles Ferraz Charles Ferraz Chief Investment Officer 2026-07-15